366 related articles for article (PubMed ID: 22918225)
1. Total ApoE and ApoE4 isoform assays in an Alzheimer's disease case-control study by targeted mass spectrometry (n=669): a pilot assay for methionine-containing proteotypic peptides.
Simon R; Girod M; Fonbonne C; Salvador A; Clément Y; Lantéri P; Amouyel P; Lambert JC; Lemoine J
Mol Cell Proteomics; 2012 Nov; 11(11):1389-403. PubMed ID: 22918225
[TBL] [Abstract][Full Text] [Related]
2. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
[TBL] [Abstract][Full Text] [Related]
3. Plasma ApoE4 Levels Are Lower than ApoE2 and ApoE3 Levels, and Not Associated with Plasma Aβ40/42 Ratio as a Biomarker of Amyloid-β Amyloidosis in Alzheimer's Disease.
Nakamura T; Kawarabayashi T; Ueda T; Shimomura S; Hoshino M; Itoh K; Ihara K; Nakaji S; Takatama M; Ikeda Y; Shoji M
J Alzheimers Dis; 2023; 93(1):333-348. PubMed ID: 36970894
[TBL] [Abstract][Full Text] [Related]
4. Assessment of peptide chemical modifications on the development of an accurate and precise multiplex selected reaction monitoring assay for apolipoprotein e isoforms.
Martínez-Morillo E; Nielsen HM; Batruch I; Drabovich AP; Begcevic I; Lopez MF; Minthon L; Bu G; Mattsson N; Portelius E; Hansson O; Diamandis EP
J Proteome Res; 2014 Feb; 13(2):1077-87. PubMed ID: 24392642
[TBL] [Abstract][Full Text] [Related]
5. 15N-labeled full-length apolipoprotein E4 as an internal standard for mass spectrometry quantification of apolipoprotein E isoforms.
Wang M; Chen J; Turko IV
Anal Chem; 2012 Oct; 84(19):8340-4. PubMed ID: 22931427
[TBL] [Abstract][Full Text] [Related]
6. Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Aβ metabolism in apoE4-targeted replacement mice.
Hu J; Liu CC; Chen XF; Zhang YW; Xu H; Bu G
Mol Neurodegener; 2015 Mar; 10():6. PubMed ID: 25871773
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E and oxidative stress in brain with relevance to Alzheimer's disease.
Butterfield DA; Mattson MP
Neurobiol Dis; 2020 May; 138():104795. PubMed ID: 32036033
[TBL] [Abstract][Full Text] [Related]
8. Human apolipoprotein E isoforms differentially affect bone mass and turnover in vivo.
Dieckmann M; Beil FT; Mueller B; Bartelt A; Marshall RP; Koehne T; Amling M; Ruether W; Cooper JA; Humphries SE; Herz J; Niemeier A
J Bone Miner Res; 2013 Feb; 28(2):236-45. PubMed ID: 22991192
[TBL] [Abstract][Full Text] [Related]
9. Peripheral apoE isoform levels in cognitively normal APOE ε3/ε4 individuals are associated with regional gray matter volume and cerebral glucose metabolism.
Nielsen HM; Chen K; Lee W; Chen Y; Bauer RJ; Reiman E; Caselli R; Bu G
Alzheimers Res Ther; 2017 Jan; 9(1):5. PubMed ID: 28137305
[TBL] [Abstract][Full Text] [Related]
10. Reduced levels of human apoE4 protein in an animal model of cognitive impairment.
Sullivan PM; Han B; Liu F; Mace BE; Ervin JF; Wu S; Koger D; Paul S; Bales KR
Neurobiol Aging; 2011 May; 32(5):791-801. PubMed ID: 19577821
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid β peptide.
Hashimoto T; Serrano-Pozo A; Hori Y; Adams KW; Takeda S; Banerji AO; Mitani A; Joyner D; Thyssen DH; Bacskai BJ; Frosch MP; Spires-Jones TL; Finn MB; Holtzman DM; Hyman BT
J Neurosci; 2012 Oct; 32(43):15181-92. PubMed ID: 23100439
[TBL] [Abstract][Full Text] [Related]
12. Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer's disease.
Aleshkov S; Abraham CR; Zannis VI
Biochemistry; 1997 Aug; 36(34):10571-80. PubMed ID: 9265639
[TBL] [Abstract][Full Text] [Related]
13. The Molecular Basis for Apolipoprotein E4 as the Major Risk Factor for Late-Onset Alzheimer's Disease.
Raulin AC; Kraft L; Al-Hilaly YK; Xue WF; McGeehan JE; Atack JR; Serpell L
J Mol Biol; 2019 May; 431(12):2248-2265. PubMed ID: 31051176
[TBL] [Abstract][Full Text] [Related]
14. APOE epsilon 3/ epsilon 4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer's disease diagnosis.
Fukumoto H; Ingelsson M; Gårevik N; Wahlund LO; Nukina N; Yaguchi Y; Shibata M; Hyman BT; Rebeck GW; Irizarry MC
Exp Neurol; 2003 Sep; 183(1):249-53. PubMed ID: 12957508
[TBL] [Abstract][Full Text] [Related]
15. Levels of soluble apolipoprotein E/amyloid-β (Aβ) complex are reduced and oligomeric Aβ increased with APOE4 and Alzheimer disease in a transgenic mouse model and human samples.
Tai LM; Bilousova T; Jungbauer L; Roeske SK; Youmans KL; Yu C; Poon WW; Cornwell LB; Miller CA; Vinters HV; Van Eldik LJ; Fardo DW; Estus S; Bu G; Gylys KH; Ladu MJ
J Biol Chem; 2013 Feb; 288(8):5914-26. PubMed ID: 23293020
[TBL] [Abstract][Full Text] [Related]
16. Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk.
Huang YA; Zhou B; Nabet AM; Wernig M; Südhof TC
J Neurosci; 2019 Sep; 39(37):7408-7427. PubMed ID: 31331998
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E isoforms in Alzheimer's disease pathology and etiology.
Baum L; Chen L; Ng HK; Pang CP
Microsc Res Tech; 2000 Aug; 50(4):278-81. PubMed ID: 10936880
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous Mass Spectrometry-Based Apolipoprotein Profiling and Apolipoprotein E Phenotyping in Patients with ASCVD and Mild Cognitive Impairment.
Begcevic Brkovic I; Zöhrer B; Scholz M; Reinicke M; Dittrich J; Kamalsada S; Baber R; Beutner F; Teren A; Engel C; Wirkner K; Thiele H; Löffler M; Riedel-Heller SG; Ceglarek U
Nutrients; 2022 Jun; 14(12):. PubMed ID: 35745204
[TBL] [Abstract][Full Text] [Related]
19. Simple and Fast Assay for Apolipoprotein E Phenotyping and Glycotyping: Discovering Isoform-Specific Glycosylation in Plasma and Cerebrospinal Fluid.
Hu Y; Meuret C; Go S; Yassine HN; Nedelkov D
J Alzheimers Dis; 2020; 76(3):883-893. PubMed ID: 32568201
[TBL] [Abstract][Full Text] [Related]
20. ApoE: In Vitro Studies of a Small Molecule Effector.
Mondal T; Wang H; DeKoster GT; Baban B; Gross ML; Frieden C
Biochemistry; 2016 May; 55(18):2613-21. PubMed ID: 27065061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
